Jan 10, 2025 08:07AM
Jan 10, 2025 08:00AM
Nov 13, 2024 04:01PM
Oct 15, 2024 08:30AM
Aug 19, 2024 06:50AM
Aug 14, 2024 04:01PM
Jul 25, 2024 08:02AM scPharmaceuticals (SCPH) Announces Filing Acceptance of sNDA Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease
Jul 25, 2024 08:00AM
May 14, 2024 04:01PM
Sep 30, 2022 08:00AM
Aug 9, 2022 07:00AM
Jul 12, 2022 08:00AM
Jul 12, 2022 08:00AM
May 16, 2022 07:10AM scPharmaceuticals Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
May 16, 2022 07:00AM
Dec 7, 2020 08:03AM
Dec 7, 2020 08:00AM
Nov 16, 2020 07:00AM
Oct 8, 2020 08:08AM
Oct 8, 2020 08:00AM
Sep 17, 2020 08:00AM scPharmaceuticals Hosting Key Opinion Leader Call on FUROSCIX® (furosemide) for subcutaneous administration
Aug 13, 2020 07:00AM
Jul 27, 2020 08:01AM
Jul 27, 2020 08:00AM
May 13, 2020 07:34AM
Jun 1, 2018 06:21AM
May 31, 2018 08:34AM
May 31, 2018 08:30AM scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®
May 7, 2018 04:01PM
May 7, 2018 04:01PM
Mar 20, 2018 07:22PM
Mar 20, 2018 07:22PM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All